66 related articles for article (PubMed ID: 14734678)
1. Transport of 99mTc-MAG3 via rat renal organic anion.
Blaufox MD
J Nucl Med; 2004 Jan; 45(1):86-8. PubMed ID: 14734678
[No Abstract] [Full Text] [Related]
2. Transport of 99mTc-MAG3 via rat renal organic anion transporter 1.
Shikano N; Kanai Y; Kawai K; Ishikawa N; Endou H
J Nucl Med; 2004 Jan; 45(1):80-5. PubMed ID: 14734677
[TBL] [Abstract][Full Text] [Related]
3. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
4. Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development.
Takahara N; Saga T; Inubushi M; Kusuhara H; Seki C; Ito S; Oyama N; Yokoyama O; Sugiyama Y; Fujibayashi Y
Nucl Med Biol; 2013 Jul; 40(5):643-50. PubMed ID: 23618840
[TBL] [Abstract][Full Text] [Related]
5. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
6. Renal clearance of technetium-99m-MAG3: normal values.
Russell CD; Li Y; Nadiye Kahraman H; Dubovsky EV
J Nucl Med; 1995 Apr; 36(4):706-8. PubMed ID: 7699471
[No Abstract] [Full Text] [Related]
7. A single-injection, two-sample method for measuring renal 99mTc-MAG3 clearance in both children and adults.
Russell CD; Taylor AT; Dubovsky EV; Eshima D
Nucl Med Biol; 1995 Jan; 22(1):55-60. PubMed ID: 7735170
[TBL] [Abstract][Full Text] [Related]
8. Exercise acutely increases renal transit time of Tc-99m mercaptoacetyltriglycine (MAG3) in a post-liver transplant patient.
Murthy R; Chahal M; Appel G; Bergmann S; Tikofsky R; Fawwaz R; Van Heertum R
Clin Nucl Med; 2006 Dec; 31(12):829-34. PubMed ID: 17117088
[TBL] [Abstract][Full Text] [Related]
9. Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance.
Hamscho N; Wilhelm A; Döbert N; Menzel C; Gossmann J; Berner U; Zaplatnikov K; Scheuermann EH; Grünwald F
Nuklearmedizin; 2005; 44(5):200-4. PubMed ID: 16395496
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
Fritzberg AR; Kasina S; Eshima D; Johnson DL
J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of Tc-99m cystine and Tc-99m MAG3 in normals and patients with renal functional impairment.
Misra M; Pradhan PK; De K; Chandra S; Das BK
Clin Nucl Med; 2009 Mar; 34(3):141-5. PubMed ID: 19352274
[TBL] [Abstract][Full Text] [Related]
12. Kidney function after nephrectomy for renal cell carcinoma.
Shirasaki Y; Tsushima T; Saika T; Nasu Y; Kumon H
Urology; 2004 Jul; 64(1):43-7; discussion 48. PubMed ID: 15245931
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic alteration of (99m)Tc-MAG3 using serum protein binding displacement method.
Nishi K; Kobayashi M; Nishii R; Shikano N; Takamura N; Kuga N; Yamasaki K; Nagamachi S; Tamura S; Otagiri M; Kawai K
Nucl Med Biol; 2013 Apr; 40(3):366-70. PubMed ID: 23312701
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of 99Tcm-MAG3 clearance.
Boivin C
Nucl Med Commun; 1999 Feb; 20(2):199-200. PubMed ID: 10088172
[No Abstract] [Full Text] [Related]
15. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
Mustafa S; Elgazzar AH
J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
17. Anomalies in hepatobiliary excretion of technetium-99m-MAG3 preparations.
Chatterjee M; Majumder A; Iyer P; Muthukrishnan G; Das MK; Ramamoorthy N; Desai CN; Banerjee S
Nucl Med Biol; 1996 Oct; 23(7):867-72. PubMed ID: 8971853
[TBL] [Abstract][Full Text] [Related]
18. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
[TBL] [Abstract][Full Text] [Related]
19. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
Taylor A; Eshima D
J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
